Patients with adequate tumor specimens were analyzed for genetic changes including isocitrate dehydrogenase 1 (IDH1) mutations, 1p/19q loss of heterozygosity (LOH) and promoter methylation of O6-methylguanine-DNA methyltransferase (MGMT). The gene discussed is IDH1; the disease is neoplasm.